Latest Breaking News On - Ls prasad kellati - Page 1 : comparemela.com

Scancell Holdings doses first patient with iSCIB1+

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), a developer of immunotherapies for cancer and infectious diseases, has reached a pivotal milestone in its.